A Phase I, Double-Blind, Randomized, Multiple-Dose, Pilot Study Comparing Xanomeline Administered Alone to Xanomeline Administered in Combination With Trospium Chloride in Normal Healthy Volunteers

Trial Profile

A Phase I, Double-Blind, Randomized, Multiple-Dose, Pilot Study Comparing Xanomeline Administered Alone to Xanomeline Administered in Combination With Trospium Chloride in Normal Healthy Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 19 May 2017

At a glance

  • Drugs Trospium chloride (Primary) ; Xanomeline
  • Indications Schizophrenia
  • Focus Adverse reactions; Proof of concept
  • Sponsors Karuna Pharmaceuticals
  • Most Recent Events

    • 19 May 2017 According to a Karuna Pharmaceuticals media release, data from this study will be presented at The American Society of Clinical Psychopharmacology (ASCP) Annual Meeting 2017.
    • 19 May 2017 According to a Karuna Pharmaceuticals media release, data from this study will be presented at The Society of Biological Psychiatry's (SOBP) 72nd Annual Scientific Program and Convention 2017.
    • 18 Apr 2017 Status changed from active, no longer recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top